At Dr. Dangs Central Lab, timely and accurate laboratory reporting is central to ensuring patient safety in clinical trials. Reporting workflows are designed to support consistency, traceability, and reliability across all phases of study execution.
To ensure continuity of testing, the laboratory maintains apple-to-apple backup across all major analytical platforms. This approach enables uninterrupted testing and ensures that defined turnaround times (TATs) are consistently met, even during periods of high testing demand.
Dr. Dangs Lab has served as a preferred central lab partner for more than 100 clinical trials and research projects, supporting a comprehensive range of safety laboratory testing. These include routine hematology, coagulation studies, lipid profile, hepatic and renal function testing, urinalysis, and pregnancy testing.
The strength of these operational systems was clearly demonstrated during COVID-19 vaccine trials, where the laboratory consistently delivered reliable turnaround times under unprecedented conditions. This experience reflects the laboratory's capacity to support large-scale, time-critical clinical research initiatives requiring speed, accuracy, and operational resilience.
